Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer
- PMID: 34511188
- DOI: 10.1016/j.soc.2021.06.010
Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer
Abstract
Over the last two decades, there have been significant changes in the management of patients with localized pancreatic cancer. The rationale for an evolution toward a neoadjuvant approach and summary of relevant clinical trials is reviewed. Controversies in identifying optimal neoadjuvant therapeutic approaches are discussed.
Keywords: CA19-9; Micro-metastatic disease; Neoadjuvant therapy; Pancreatic cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical